Mr Mihir Gandhi
MSc, CStat, Csci
Head of Biostatistics, SCRI
Associate, Duke-NUS Graduate Medical School Singapore
Mihir has more than 10 years of academic and industry experience in statistical and clinical research for wide therapeutic areas, ranging from paediatrics and oncology to immunology. His expertise is in planning and designing of clinical trials of phase I to III. He has also worked on Medical Device, Bioequivalence and Bridging studies. He has also authored more than 35 peer-reviewed international journals.
- Health-related quality of life
- Health economic evaluation
- Child growth and development
Key Publications (1-3 publications only)
- Gandhi M, Tan SB, Chung Yaw Fui A, Machin D. On developing a pragmatic strategy for clinical trials: A case study of hepatocellular carcinoma. Contemporary Clinical Trials, 2015; 43:252-9.
- Phillips R, Gandhi M, Cheung YB, et al. Summary scores captured changes in subjects’ QoL as measured by the multiple scales of the EORTC QLQ-C30. Journal of Clinical Epidemiology, 2015; 68(8):895-902.
- Gandhi M, Thumboo J, Luo N, Wee HL, Cheung YB. Do chronic disease patients value generic health states differently from individuals with no chronic disease? A case of a multicultural Asian population. Health and Quality of Life Outcomes, 2015; 13:8.
- Gandhi M, Mukherjee B, Biswas D. A Bayesian approach for inference from a bridging study with binary outcomes. Journal of Biopharmaceutical Statistics, 2012; 22(5):935-51.
- Gandhi M, Ashorn P, Maleta K, Teivaanmäki T, Duan X, Cheung YB. Height gain during early childhood is an important predictor of schooling and mathematics ability outcomes. Acta Paediatrica, 2011; 100(8):1113-8.